7 results
Conversion - Epoetin alfa (Procrit®) to Darbepoetin alfa (Aranesp™)

#Epoetin #Darbepoetin #Erythropoietin #Conversion #Table #ESAs #Procrit #Aranesp
Conversion - Epoetin ... Darbepoetin alfa (Aranesp ... #Table #ESAs #Procrit ... #Aranesp #Pharmacology ... #Hematology #Nephrology
Angiotensin Receptor Blocker (ARB) Antihypertensive Dose Comparison

#Pharmacology #Angiotensin #Receptor #Blocker #ARB #Conversion #Table #Dose #Dosages

** GrepMed
Angiotensin Receptor ... Comparison #Pharmacology ... #Angiotensin #Receptor ... #Blocker #ARB # ... Conversion #Table
Angiotensin-Converting Enzyme Inhibitors - Inhibit the conversion of AngI to AngII
 • Captopril, Lisinopril, Enalapril, Benazepril,
- Inhibit the conversion ... Blockers - Block AT1 receptors ... Inhibitors #ACEis #ARBs ... #pharmacology # ... table #medications
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Angiotensin Receptor ... initiating an ARB ... #Blockers #ARB ... #Conversion #Table ... #Dosing #Pharmacology
Table 1. Estimated Darbepoetin alfa Starting Doses (mcg/week) for Patients With CKD on Dialysis Based on
Table 1. ... Starting Doses (mcg ... available data are ... #Table #ESAs #Procrit ... #Aranesp
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
ANGIOTENSIN II RECEPTOR ... angiotensin II receptor ... ReceptorBlocker #Pharmacology ... #Conversion #Switching ... #Equivalent #Table
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Skin Disease Classification ... Malignancy (e.g. hematologic ... Antineuronal, Anti-NMDA receptor ... vein thrombosis Hematologic ... La, anti-Jo-1, SCL